Blockchain Registration Transaction Record

Pancreatic Cancer on the Rise: Promising Treatment in Development by Oncolytics Biotech

Pancreatic cancer incidence on the rise, with promising treatment in development by Oncolytics Biotech to improve survival rates and impact patients' lives. Learn more about the development of pelareorep and its potential in pancreatic cancer treatment.

This news matters as the incidence of pancreatic cancer is increasing, with younger adults and women being diagnosed at alarming rates. The development of immunotherapeutic agent pelareorep by Oncolytics Biotech offers hope for improved treatment and survival rates, potentially impacting the lives of pancreatic cancer patients.